A Service For Professionals Tuesday, November 21, 2017
Contact (202) 540-8337
Arab League News Today
A Service For Professionals Tuesday, November 21, 2017 11614 Sources 416,808,783 Articles 3,022,490 Readers
Contact (202) 540-8337

United States Pediatric Vaccine market is Expected to reach US$ 10 Billion by 2024

Precisemarketreports.com add new report “United States Pediatric Vaccine Market” United States Pediatric Vaccine is Projected to Reach significantly By 2024

PUNE, MAHARASHTRA, INDIA, October 16, 2017 /EINPresswire.com/ -- Growth in US pediatric vaccine market can be attributed to factors such as increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccine development.

The research report titled “United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States pediatric vaccine market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues and provides forecasts through 2024. The report also provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccine market.

The report concludes with the profiles of major players in the United States pediatric vaccine market. The key market players are evaluated on various parameters such as company overview, pediatric vaccine portfolios and latest development & trends of the pediatric vaccine market.

Get a sample report at https://www.precisemarketreports.com/report/sample/pmr-23486 .

Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:

Diphtheria, Tetanus & Pertussis (DTap)
Hepatitis A
Varicella/Chicken Pox
Pneumococcal
Haemophilus Influenzae Type B (HIB)
Polio
Rotavirus
Hepatitis B
Influenza Pediatric
Measles, Mumps & Rubella (MMR)


Key Companies Covered in the Report are as follows:

Sanofi Pasteur
GlaxoSmithKline(GSK)
Merck & Co.
Pfizer Inc
Grifols

Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
It provides a growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed based on how the market is predicted to grow
It helps in understanding the key product segments and their future
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.

Access Complete Reports with 6 Table of Figure, 115 Report Pages and United States Major Key Players Profile at https://www.precisemarketreports.com/reports/view/pmr-23486-United-States-Pediatric-Vaccine-Market-2017--Demand-Insights-Analysis-Opportunities-Segmentation-and-Forecast-to-2024 .

List of Figures:

Figure 2–1: United States Pediatric Vaccine Market (Million US$), 2010 – 2016
Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2017 – 2024
Figure 4–19: DTap Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–20: DTap Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–21: Number of Children Being Vaccinated with DTap Vaccine (in Million),2010 – 2016
Figure 4–22: Number of Children Being Vaccinated with DTap Vaccine Forecast (in Million),2017 – 2024
Figure 4–23: DTap Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–24: DTap Vaccine Market Value Forecast (in Million US$), 2017 – 2024
Figure 4–43: Hepatitis A Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–44: Hepatitis A Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–45: Number of Children Being Vaccinated with Hepatitis A Vaccine (in Million),2010 – 2016
Figure 4–46: Number of Children Being Vaccinated with Hepatitis A Vaccine Forecast (in Million),2017 – 2024
Figure 4–47: Hepatitis A Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–48: Hepatitis A Vaccine Market Value Forecast (in Million US$), 2017 – 2024
Figure 4–49: Varicella Vaccine Doses Administered (in Million), 2010–2016
Figure 4–50: Varicella Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–51: Number of Children Being Vaccinated with Varicella Vaccine (in Million),2010 – 2016
Figure 4–52: Number of Children Being Vaccinated with Varicella Vaccine Forecast (in Million),2017 – 2024
Figure 4–53: Varicella Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–54: Varicella Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Direct Purchase this report only USD 850 with major key players profile, current and future scenario of this topic at https://www.precisemarketreports.com/paypal/checkout/pmr-23486 .

Figure 4–25: Pneumococcal Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–26: Pneumococcal Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–27: Number of Children Being Vaccinated with Pneumococcal Vaccine (in Million),2010 – 2016
Figure 4–28: Number of Children Being Vaccinated with Pneumococcal Vaccine Forecast (in Million),2017 – 2024
Figure 4–29: Pneumococcal Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–30: Pneumococcal Vaccine Market Value Forecast (in Million US$), 2017 – 2024
Figure 4–7: HIB Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–8: HIB Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–9: Number of Children Being Vaccinated with HIB Vaccine (in Million),2010 – 2016
Figure 4–10: Number of Children Being Vaccinated with HIB Vaccine Forecast (in Million),2017 – 2024
Figure 4–11: HIB Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–12: HIB Vaccine Market Value Forecast (in Million US$), 2017 – 2024
Figure 4–13: Polio Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–14: Polio Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–15: Number of Children Being Vaccinated with Polio Vaccine (in Million),2010 – 2016
Figure 4–16: Number of Children Being Vaccinated with Polio Vaccine Forecast (in Million),2017 – 2024
Figure 4–17: Polio Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–18: Polio Vaccine Market Value Forecast (in Million US$), 2017 – 2024
Figure 4–31: Rotavirus Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–32: Rotavirus Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–33: Number of Children Being Vaccinated with Rotavirus Vaccine (in Million),2010 – 2016
Figure 4–34: Number of Children Being Vaccinated with Rotavirus Vaccine Forecast (in Million),2017 – 2024
Figure 4–35: Rotavirus Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–36: Rotavirus Vaccine Market Value Forecast (in Million US$), 2017 – 2024
Figure 4–37: Hepatitis B Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–38: Hepatitis B Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–39: Number of Children Being Vaccinated with Hepatitis B Vaccine (in Million),2010 – 2016
Figure 4–40: Number of Children Being Vaccinated with Hepatitis B Vaccine Forecast (in Million),2017 – 2024
Figure 4–41: Hepatitis B Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–42: Hepatitis B Vaccine Market Value Forecast (in Million US$), 2017 – 2024
Figure 4–55: Influenza Pediatric Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–56: Influenza Pediatric Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–57: Number of Children Being Vaccinated with Influenza Pediatric Vaccine (in Million),2010 – 2016
Figure 4–58: Number of Children Being Vaccinated with Influenza Pediatric Vaccine Forecast (in Million),2017 – 2024
Figure 4–59: Influenza Pediatric Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–60: Influenza Pediatric Vaccine Market Value Forecast (in Million US$), 2017 – 2024
Figure 4–1: MMR Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–2: MMR Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–3: Number of Children Being Vaccinated with MMR Vaccine (in Million),2010 – 2016
Figure 4–4: Number of Children Being Vaccinated with MMR Vaccine Forecast (in Million),2017 – 2024
Figure 4–5: MMR Vaccine Market Value (in Million US$), 2010 – 2016
Figure 4–6: MMR Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Parag Pingale
Precise Market Reports
+1323744-6588
email us here

Powered by EIN Presswire